These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27448505)

  • 61. Detection of a fourth orbivirus non-structural protein.
    Belhouchet M; Mohd Jaafar F; Firth AE; Grimes JM; Mertens PP; Attoui H
    PLoS One; 2011; 6(10):e25697. PubMed ID: 22022432
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Virus-derived tubular structure displaying foreign sequences on the surface elicit CD4+ Th cell and protective humoral responses.
    Ghosh MK; Borca MV; Roy P
    Virology; 2002 Oct; 302(2):383-92. PubMed ID: 12441082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release.
    Beaton AR; Rodriguez J; Reddy YK; Roy P
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13154-9. PubMed ID: 12235365
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of two African horse sickness virus nonstructural proteins, NS1 and NS3.
    van Staden V; Smit CC; Stoltz MA; Maree FF; Huismans H
    Arch Virol Suppl; 1998; 14():251-8. PubMed ID: 9785511
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adaptation of bluetongue virus in mosquito cells results in overexpression of NS3 proteins and release of virus particles.
    Guirakhoo F; Catalan JA; Monath TP
    Arch Virol; 1995; 140(5):967-74. PubMed ID: 7605208
    [TBL] [Abstract][Full Text] [Related]  

  • 66. NS3 of bluetongue virus interferes with the induction of type I interferon.
    Chauveau E; Doceul V; Lara E; Breard E; Sailleau C; Vidalain PO; Meurs EF; Dabo S; Schwartz-Cornil I; Zientara S; Vitour D
    J Virol; 2013 Jul; 87(14):8241-6. PubMed ID: 23658442
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The NS3 protein of bluetongue virus exhibits viroporin-like properties.
    Han Z; Harty RN
    J Biol Chem; 2004 Oct; 279(41):43092-7. PubMed ID: 15292261
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NTP binding and phosphohydrolase activity associated with purified bluetongue virus non-structural protein NS2.
    Horscroft NJ; Roy P
    J Gen Virol; 2000 Aug; 81(Pt 8):1961-1965. PubMed ID: 10900034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Engineering Recombinant Virus-like Nanoparticles from Plants for Cellular Delivery.
    Brillault L; Jutras PV; Dashti N; Thuenemann EC; Morgan G; Lomonossoff GP; Landsberg MJ; Sainsbury F
    ACS Nano; 2017 Apr; 11(4):3476-3484. PubMed ID: 28198180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Expression of NS5a strong antigenic regions gene of hepatitis C virus in E.coli and detection of their antigenicity].
    Dou XG; Li ZW; Khudyakov Y; Fields H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):306. PubMed ID: 12223151
    [No Abstract]   [Full Text] [Related]  

  • 71. [The significance of the structural characteristics of the agent for the problems of immunization against blue tongue].
    Müller H
    Tierarztl Prax; 1991 Dec; 19(6):591-5. PubMed ID: 1665600
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Production of recombinant non-structural protein-3 hydrophobic domain deletion (NS3ΔHD) protein of bluetongue virus from prokaryotic expression system as an efficient diagnostic reagent.
    Mohanty NN; Chacko N; Biswas SK; Chand K; Pandey AB; Mondal B; Hemadri D; Shivachandra SB
    Biologicals; 2016 Sep; 44(5):352-9. PubMed ID: 27448505
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An efficient production of hybrid recombinant protein comprising non-structural proteins (NS 1 & NS 3) of bluetongue virus in prokaryotic expression system.
    Mohanty NN; Shivachandra SB; Biswas SK; Nagaraj V; Basheer TJ; Narendra Babu D; Yogisharadhya R; Hemadri D
    Protein Expr Purif; 2019 Mar; 155():15-20. PubMed ID: 30217599
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.
    Barros SC; Cruz B; Luís TM; Ramos F; Fagulha T; Duarte M; Henriques M; Fevereiro M
    Vet Microbiol; 2009 Jun; 137(3-4):252-9. PubMed ID: 19233575
    [TBL] [Abstract][Full Text] [Related]  

  • 75. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
    Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
    Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of recombinant NS1-NS3 antigen based indirect ELISA for detection of bluetongue antibodies in sheep.
    Mohanty NN; Hemadri D; Munivenkatarayappa A; Shetty N; Subramanyam V; Biswas SK; Chanda MM; Shivachandra SB
    J Immunol Methods; 2021 Mar; 490():112959. PubMed ID: 33412173
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.